GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

IRWD · Mar 31, 2025

IRONWOOD PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001558370-25-007406General Corporate

Debt relative to revenueRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.debt_to_revenue

484.07% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.08% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

48.50% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-45.05% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-70.75% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

66.67% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

12.86% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History6 statesHistory building

Mar 31, 20250/7 normalizedLevel 3 Jun 30, 20250/7 normalizedLevel 3 Sep 30, 20250/7 normalizedLevel 3 Dec 31, 20250/6 normalizedLevel 3 Mar 31, 20264/5 normalizedLevel 3 Jun 30, 20264/5 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 0.04%
Current: 0.08%
Delta: 0.03%

Cash Generation Increased

Previous: 29.47%
Current: 48.50%
Delta: 19.03%

Profitability Decreased

Previous: 26.50%
Current: -70.75%
Delta: -97.25%

R And D Intensity Increased

Previous: 31.71%
Current: 66.67%
Delta: 34.97%

Sbc Intensity Increased

Previous: 8.49%
Current: 12.86%
Delta: 4.37%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · IRWD Fundamental State →Transitioned To · IRWD CAPEX_INTENSITY_INCREASED →Transitioned To · IRWD CASH_GENERATION_INCREASED →Transitioned To · IRWD PROFITABILITY_DECREASED →Transitioned To · IRWD R_AND_D_INTENSITY_INCREASED →Transitioned To · IRWD SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.